GLUCOSTAT
Background
Flowsion A/S (www.flowsion.dk) has developed the GlycostatTM system, intended to continuously measure, record and track the blood glucose level (BGL) in critically ill patients [i.e., those patients under intensive-care treatment within the operating rooms, emergency department, post-anaesthesia recovery unit and an Intensive Care Unit (ICU)]. In addition Glycostat has an algorithm which gives advice on the insulin infusion rate which -if adhered to- gives good glycemic control.
Purpose
The primary objective of this validation study is to verify the Glycostat system`s ability to accurately measure blood glucose levels. Secondly to verify the GlycostatTM System ability to secure good glycemic control by means of its algorithm. The accuracy of Glycostat, expressed by the Clark-Error-Grid using the measurements of a Blood gas instrument as the reference is to be confirmed.
In charge
The doctor in charge of the Glucostat-project is MD, PhD-student Anne-Sophie Worm Fenger, supervised by prof. Kirsten Møller. If you have any questions for the project, please feel free to contact us.
